Celsius Therapeutics is based in Cambridge. It has raised $148M in total funding. Latest round: Series B.
Celsius Therapeutics is based in Cambridge. Celsius Therapeutics has raised $148M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for Celsius Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Third Rock Ventures, Casdin Capital, Alexandria Venture Investments, GV, Heritage Provider Network, Amgen Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.
Totals shown for Celsius Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026